MATR3 disruption in human and mouse associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosus

Autor: Xueping Fan, Anna Kamp, Ivan P. Moskowitz, Fabiola Quintero-Rivera, Anne W. Higgins, Ronald Berezney, Amy E. Roberts, Kasper Lage, Cynthia C. Morton, Ji Hyun Lee, Ihn Sik Seong, Weining Lu, Ronald V. Lacro, Raymond M. Anchan, Xuchen Hu, Qiongchao J. Xi, Bruce D. Gelb, Joanna Tao, James F. Gusella, Lily Y. Lu, Richard L. Maas, Kim M. Keppler-Noreuil
Rok vydání: 2015
Předmět:
Aortic valve
Male
Heart disease
Heart Valve Diseases
Cardiovascular
Medical and Health Sciences
Translocation
Genetic

Mice
Bicuspid aortic valve
Bicuspid Aortic Valve Disease
Nuclear Matrix-Associated Proteins
Ductus arteriosus
2.1 Biological and endogenous factors
Ventricular outflow tract
Aetiology
Child
Ductus Arteriosus
Patent

Genetics (clinical)
Pediatric
Genetics & Heredity
DUCTUS ARTERIOSUS PATENT
RNA-Binding Proteins
General Medicine
Anatomy
Articles
Biological Sciences
DNA-Binding Proteins
Heart Disease
medicine.anatomical_structure
Aortic Valve
Child
Preschool

cardiovascular system
Cardiology
Patent
Female
endocrine system
medicine.medical_specialty
congenital
hereditary
and neonatal diseases and abnormalities

Adolescent
Heart Ventricles
Translocation
Biology
Aortic Coarctation
Genetic
Insertional
Internal medicine
Genetics
medicine
Animals
Humans
Gene Silencing
Preschool
Molecular Biology
Infant
Newborn

Infant
Ductus Arteriosus
Newborn
medicine.disease
Infant newborn
Mutagenesis
Insertional

Mutagenesis
Congenital Structural Anomalies
Zdroj: Human Molecular Genetics
Human molecular genetics, vol 24, iss 8
ISSN: 1460-2083
Popis: Cardiac left ventricular outflow tract (LVOT) defects represent a common but heterogeneous subset of congenital heart disease for which gene identification has been difficult. We describe a 46,XY,t(1;5)(p36.11;q31.2)dn translocation carrier with pervasive developmental delay who also exhibited LVOT defects, including bicuspid aortic valve (BAV), coarctation of the aorta (CoA) and patent ductus arteriosus (PDA). The 1p breakpoint disrupts the 5' UTR of AHDC1, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea. Am. J. Hum. Genet., 94, 784-789]. On the other hand, the 5q translocation breakpoint disrupts the 3' UTR of MATR3, which encodes the nuclear matrix protein Matrin 3, and mouse Matr3 is strongly expressed in neural crest, developing heart and great vessels, whereas Ahdc1 is not. To further establish MATR3 3' UTR disruption as the cause of the proband's LVOT defects, we prepared a mouse Matr3(Gt-ex13) gene trap allele that disrupted the 3' portion of the gene. Matr3(Gt-ex13) homozygotes are early embryo lethal, but Matr3(Gt-ex13) heterozygotes exhibit incompletely penetrant BAV, CoA and PDA phenotypes similar to those in the human proband, as well as ventricular septal defect (VSD) and double-outlet right ventricle (DORV). Both the human MATR3 translocation breakpoint and the mouse Matr3(Gt-ex13) gene trap insertion disturb the polyadenylation of MATR3 transcripts and alter Matrin 3 protein expression, quantitatively or qualitatively. Thus, subtle perturbations in Matrin 3 expression appear to cause similar LVOT defects in human and mouse.
Databáze: OpenAIRE